Evidence map›Paper›PMID 36294841›Full record

ArticleJournal of personalized medicine2022

Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis.

Giovanni Peretto, Simone Gulletta, Massimo Slavich, Corrado Campochiaro, Davide Vignale, Giacomo De Luca, Anna Palmisano, Andrea Villatore, Stefania Rizzo, Giulio Cavalli and 9 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04521790 (Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04521790 recruitingnot on this map

Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management

Typeobservational_patient_registrySponsorScientific Institute San RaffaeleRan2018 to 2035Enrolled1,000ConditionsMyocarditis, Ventricular Arrythmia, Inflammatory Cardiomyopathy, Genetic PredispositionArmssupport treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Giovanni PerettoDepartment of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0003-1815-4000
Simone GullettaDepartment of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Massimo SlavichDepartment of Cardiology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Corrado CampochiaroMyocarditis Disease Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0001-6806-3794
Davide VignaleMyocarditis Disease Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Giacomo De LucaMyocarditis Disease Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Anna PalmisanoMyocarditis Disease Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0002-1564-2060
Andrea VillatoreDepartment of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0002-2858-1404
Stefania RizzoDepartment of Cardiac Thoracic Vascular Sciences and Public Health, Cardiovascular Pathology, Padua University, 35128 Padua, Italy.ORCID 0000-0001-5969-4412
Giulio CavalliSchool of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy.
Monica De GaspariDepartment of Cardiac Thoracic Vascular Sciences and Public Health, Cardiovascular Pathology, Padua University, 35128 Padua, Italy.ORCID 0000-0001-9528-4883
Elena BusnardoMyocarditis Disease Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Luigi GianolliNuclear Medicine Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Lorenzo DagnaSchool of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy.ORCID 0000-0002-7428-315X
Cristina BassoDepartment of Cardiac Thoracic Vascular Sciences and Public Health, Cardiovascular Pathology, Padua University, 35128 Padua, Italy.ORCID 0000-0002-0195-9753
Antonio EspositoMyocarditis Disease Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0002-1170-6266
Simone SalaDepartment of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0003-3303-8892
Paolo Della BellaDepartment of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Patrizio MazzoneDepartment of Cardiac Electrophysiology and Arrhythmology, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Vita-Salute San Raffaele University · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background. Exercise stress test (EST) has been scarcely investigated in patients with arrhythmic myocarditis. Objectives. To report the results of EST late after myocarditis with arrhythmic vs. nonarrhythmic presentation. Methods. We enrolled consecutive adult patients with EST performed at least six months after acute myocarditis was diagnosed using gold-standard techniques. Patients with ventricular arrhythmia (VA) at presentation were compared with the nonarrhythmic group. Adverse events occurring during follow-up after EST included cardiac death, disease-related rehospitalization, malignant VA, and proven active myocarditis. Results. The study cohort was composed of 128 patients (age 41 ± 9 y, 70% males) undergoing EST after myocarditis. Of them, 64 (50%) had arrhythmic presentation. EST was performed after 15 ± 4 months from initial diagnosis, and was conducted on betablockers in 75 cases (59%). During EST, VA were more common in the arrhythmic group (43 vs. 4, p < 0.001), whereas signs and symptoms of ischemia were more prevalent in the nonarrhythmic one (6 vs. 1, p = 0.115). By 58-month mean follow-up, 52 patients (41%) experienced adverse events, with a greater prevalence among arrhythmic patients (39 vs. 13, p < 0.001). As documented both in the arrhythmic and nonarrhythmic subgroups, patients had greater prevalence of adverse events following a positive EST (40/54 vs. 12/74 with negative EST, p < 0.001). Electrocardiographic features of VA during EST correlated with the subsequent inflammatory restaging of myocarditis. Nonarrhythmic patients with uneventful EST both on- and off-treatment were free from subsequent adverse events. Conclusions. Late after the arrhythmic presentation of myocarditis, EST was frequently associated with recurrent VA. In both arrhythmic and nonarrhythmic myocarditis, EST abnormalities correlated with subsequent adverse outcomes.

Indexed as

cardiac magnetic resonanceendomyocardial biopsyexercise stress testmyocarditisphysical activityventricular arrhythmia

Identifiers

PMID36294841
PMCPMC9605006
OpenAlexW4304806838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.